AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9209661
Drug: Five courses
RxNorm normalized name: fivehorn smotherweed pollen extract
DrugBank: Bassia hyssopifolia pollen (DB10941)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Five courses of carboplatin 400 mg/m2 or cisplatin 75 mg/m2
Trial: 9209661
Drug: Eight courses
RxNorm normalized name: OC Eight
DrugBank: Benzoyl peroxide (DB09096)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eight courses of carboplatin 400 mg/m2 or cisplatin 75 mg/m2
Trial: 8429800
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (2 mg oestradiol (E2) and 1 mg norethisterone acetate (NETA) daily)
Trial: 8429800
Drug: Sequential therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sequential therapy (2 mg E2 for 12 days, 2 mg E2 and 1 mg NETA for 10 days, and 1 mg E2 for 6 days)
Trial: 22525910
Drug: Nomegestrol acetate
RxNorm normalized name: nomegestrol acetate
DrugBank: Nomegestrol acetate (DB13981)
FDA approved: no
EMA approved: yes
PMDA approved: no
Description: Nomegestrol acetate (2.5 mg) and 17β‐E2 (1.5 mg) in a 24‐4‐day regimen
Trial: 22525910
Drug: Drospirenone (3.0
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drospirenone (3.0 mg) and ethinyl E2 (30 micrograms) in a 21‐7‐day regimen
Trial: 20635912
Drug: Immunotherapy with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immunotherapy with heat-killed Mycobacterium vaccae (SRL172)
Trial: 3739820
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of nicotine
Trial: 3739820
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose of nicotine
Trial: 20332142
Drug: Temsirolimus (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temsirolimus (25 mg)
Trial: 20332142
Drug: Temsirolimus (15
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temsirolimus (15 mg) + IFN-alpha
Trial: 10081528
Drug: Paracetamol 1
RxNorm normalized name: Paracetamol 1 g oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paracetamol 1 g given rectally
Trial: 7567210
Drug: Inhaled methacholine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled methacholine (MCH)
Trial: 6778324
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V (55 mg/kg/day)
Trial: 6778324
Drug: Penicillin V
RxNorm normalized name: Penicillin V
DrugBank: Phenoxymethylpenicillin (DB00417)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Penicillin V (55 mg/kg/day) and Placebo
Trial: 28790113
Drug: SR48692 (NTSR1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SR48692 (NTSR1 antagonist) combined with carboplatin
Trial: 25801542
Drug: 150 mg
RxNorm normalized name: pectin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 mg intravenous fosaprepitant (NKI group)
Trial: 25801542
Drug: 4 mg
RxNorm normalized name: lutein 4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 4 mg ondansetron (ONS group)
Trial: 12464713
Drug: Piracetam up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Piracetam up to 1,200 mg/day
Trial: 15003745
Drug: Autogenic training
RxNorm normalized name: Autogene cevumeran
DrugBank: Autogene cevumeran (DB17497)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Autogenic training (AT) for 2 months, weekly sessions
Trial: 9566819
Drug: a‐interferon (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: a‐interferon (10 million units then 5 million units three times weekly for 6 to 12 months)
Trial: 3338249
Drug: Large protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Large protein load (1.35 g/kg)
Trial: 3338249
Drug: Moderate protein
RxNorm normalized name: protein C
DrugBank: Protein C (DB11312)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate protein load (1.08 g/kg)
Trial: 3338249
Drug: Mild protein
RxNorm normalized name: mild silver protein
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mild protein load (0.55 g/kg)
Trial: 28558062
Drug: AmBisome monotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AmBisome monotherapy (5 mg/kg single dose)
Trial: 28558062
Drug: AmBisome +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AmBisome + paromomycin (5 mg/kg single dose + 10 days of paromomycin at 15 mg/kg/day)
Trial: 28558062
Drug: AmBisome +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AmBisome + miltefosine (5 mg/kg single dose + 7 subsequent days of miltefosine at 2.5 mg/kg/day)
Trial: 28558062
Drug: Paromomycin +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paromomycin + miltefosine (10 days of paromomycin at 15 mg/kg/day + miltefosine at 2.5 mg/kg/day)
Trial: 27367521
Drug: TB treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: TB treatment
Trial: 12020525
Drug: Albuterol inhaler
RxNorm normalized name: Albuterol 0.09 MG/1 ACTUATION Inhalation Aerosol Powder [ALBUTEROL INHALER]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol inhaler
Trial: 16820579
Drug: GIK (40%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GIK (40% dextrose, K+ 100 mmol.L(‐1), insulin 70 u.L(‐1); 0.75 mL.kg(‐1).h(‐1) for 6 hours after aortic cross-clamp removal)
Trial: 15229965
Drug: human recombinant
RxNorm normalized name: Human recombinant AP
DrugBank: Recombinant human alkaline phosphatase (DB17672)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: human recombinant growth hormone (GH) for 6 months
Trial: 9232301
Drug: Sublingual midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Sublingual midazolam 7.5 mg
Trial: 14591268
Drug: Treatment focusing
RxNorm normalized name: ficusin
DrugBank: Psoralen (DB18665)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment focusing on psychosocial issues
Trial: 8545150
Drug: Oral sumatriptan
RxNorm normalized name: Sumatriptan
DrugBank: Sumatriptan (DB00669)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral sumatriptan (Imitrex, Glaxo)
Trial: 1675576
Drug: Betaxolol 10
RxNorm normalized name: betaxolol 10 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betaxolol 10 mg (B10)
Trial: 1975196
Drug: Betaxolol 20
RxNorm normalized name: betaxolol 20 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betaxolol 20 mg (B20)
Trial: 1675576
Drug: Betaxolol 40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betaxolol 40 mg (B40)
Trial: 1675576
Drug: Betaxolol 80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betaxolol 80 mg (B80)
Trial: 1975196
Drug: Betaxolol (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Betaxolol (all doses)
Trial: 28610572
Drug: Intraperitoneal normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal normal saline infusion with pulmonary recruitment maneuver (pressure of 40 cm H2O)
Trial: 28610572
Drug: Intraperitoneal normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraperitoneal normal saline infusion with pulmonary recruitment maneuver
Trial: 17998306
Drug: Antidepressant pharmacotherapy
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant pharmacotherapy in comparator trials
Trial: 17998306
Drug: Antidepressant pharmacotherapy
RxNorm normalized name: ANTIDEPRESSANTS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant pharmacotherapy in placebo-controlled trials
Trial: 15689713
Drug: Interferon-alpha (IFN-alpha)
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon-alpha (IFN-alpha) administered intramuscularly at 9 x 10 IU daily for the first 4 weeks and then three times per week for the next 20 weeks.
Trial: 12804846
Drug: 20 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 micrograms of yeast-derived recombinant hepatitis B vaccine (Heberbiovac HB)
Trial: 12804846
Drug: 10 micrograms
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 micrograms of yeast-derived recombinant hepatitis B vaccine (Heberbiovac HB)
Trial: 11229782
Drug: Antidepressant drugs
RxNorm normalized name: MAO A Inhibitors, antidepressant drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant drugs (specific drugs not mentioned)
Trial: 7126388
Drug: Propranolol (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol (2 to 16 mg)
Trial: 7126388
Drug: Labetalol (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Labetalol (10 to 80 mg)
Trial: 23581606
Drug: Liquid silicone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid silicone gel (LSG) applied to hypertrophic scars (HS group)
Trial: 23581606
Drug: Silicone gel
RxNorm normalized name: SILTREX Silicone Gel-Pad
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Silicone gel alone (control for HS group)
Trial: 23581606
Drug: Liquid silicone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liquid silicone gel (LSG) applied to minor keloids (KS group)
Trial: 22931975
Drug: Sevoflurane at
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevoflurane at various concentrations (0.2% to 3.4%) combined with remifentanil (1, 3, 6, and 10 ng/ml)
Trial: 22931975
Drug: Sevoflurane and
RxNorm normalized name: Sevoflurane
DrugBank: Sevoflurane (DB01236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Sevoflurane and remifentanil combination
Trial: 19778675
Drug: Cardiac resynchronization
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac resynchronization therapy (CRT) with apical lead position
Trial: 19778675
Drug: Cardiac resynchronization
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac resynchronization therapy (CRT) with midventricular lead position
Trial: 19778675
Drug: Cardiac resynchronization
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac resynchronization therapy (CRT) with basal lead position
Trial: 17519258
Drug: Active pulsed
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active pulsed magnetic field therapy (PMFT) for 30 min (1.25 Hz, 3 ms width, 600 Gauss)
Trial: 17519258
Drug: Sham pulsed
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham pulsed magnetic field therapy (deactivated device) for 30 min
Trial: 6093524
Drug: Ceftriaxone 1
RxNorm normalized name: ceftriaxone 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone 1 g once daily
Trial: 15239219
Drug: Standard therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard therapy (second‐generation cephalosporin, broad‐spectrum penicillin or a combination of aminopenicillin and beta‐lactamase inhibitor)
Trial: 9875190
Drug: Topical class
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical class 3 corticosteroids
Trial: 9875190
Drug: Topical class
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical class 4 corticosteroids
Trial: 9875190
Drug: Oral methoxsalen
RxNorm normalized name: Methoxsalen
DrugBank: Methoxsalen (DB00553)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral methoxsalen plus sunlight
Trial: 9875190
Drug: Oral psoralen
RxNorm normalized name: Psoralen
DrugBank: Psoralen (DB18665)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral psoralen plus sunlight
Trial: 9875190
Drug: Oral trioxsalen
RxNorm normalized name: Trioxsalen
DrugBank: Trioxsalen (DB04571)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral trioxsalen plus sunlight
Trial: 9875190
Drug: Oral methoxsalen
RxNorm normalized name: Methoxsalen
DrugBank: Methoxsalen (DB00553)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral methoxsalen plus UV‐A therapy
Trial: 7662616
Drug: Gelatin capsules
RxNorm normalized name: Gelatin Capsules
DrugBank: Gelatin (DB11242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gelatin capsules coated with 20% w/v sodium alginate
Trial: 7662616
Drug: Uncoated gelatin
RxNorm normalized name: Gelatin
DrugBank: Gelatin (DB11242)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Uncoated gelatin capsules
Trial: 2748113
Drug: Epinephrine treatment
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine treatment with Ocufen (flurbiprofen)
Trial: 2748113
Drug: Epinephrine treatment
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine treatment with Indocid (indomethacin)
Trial: 7006581
Drug: Epinephrine treatment
RxNorm normalized name: Epinephrine
DrugBank: Epinephrine (DB00668)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Epinephrine treatment alone
Trial: 201786
Drug: Pivmecillinam 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pivmecillinam 400 mg per day
Trial: 201786
Drug: Amoxicillin 2000
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin 2000 mg per day
Trial: 28273285
Drug: Heparin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin plus optional GPIs (control group)
Trial: 21737486
Drug: FDTV 180
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FDTV 180 mg + T 2 mg, once a day
Trial: 21737486
Drug: T 2
RxNorm normalized name: EVT 201
DrugBank: EVT 201 (DB05721)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: T 2 mg once a day
Trial: 15254051
Drug: CEE +
RxNorm normalized name: Conjugated Estrogen Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE + MPA continuous (10 mg on days 1 to 12 per 28‐day cycle)
Trial: 15254051
Drug: CEE +
RxNorm normalized name: Conjugated Estrogen Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE + MPA cyclical (10 mg on days 1 to 12 per 28‐day cycle)
Trial: 15254051
Drug: CEE +
RxNorm normalized name: Conjugated Estrogen Plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE + MP (200 mg on days 1 to 12 per 28‐day cycle)
Trial: 29381666
Drug: CEE (0.625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CEE (0.625 mg/d)
Trial: 11177038
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate aqueous nasal spray, 200 microg once daily
Trial: 2570798
Drug: Terfenadine, 60
RxNorm normalized name: Terfenadine, 60 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine, 60 mg twice daily
Trial: 2418304
Drug: HOE 498
RxNorm normalized name: CASTOR OIL 3 mg in 30 mg / ROSEMARY 4.5 mg in 30 mg / TOCOPHEROL 9 mg in 30 mg TOPICAL LIQUID [HOEGOA Herbal Hair Growth OiI]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HOE 498 (20 mg)
Trial: 2992562
Drug: HOE 498
RxNorm normalized name: CASTOR OIL 3 mg in 30 mg / ROSEMARY 4.5 mg in 30 mg / TOCOPHEROL 9 mg in 30 mg TOPICAL LIQUID [HOEGOA Herbal Hair Growth OiI]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HOE 498 (50 mg)
Trial: 2992562
Drug: HOE 498
RxNorm normalized name: CASTOR OIL 3 mg in 30 mg / ROSEMARY 4.5 mg in 30 mg / TOCOPHEROL 9 mg in 30 mg TOPICAL LIQUID [HOEGOA Herbal Hair Growth OiI]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: HOE 498 (all doses)
Trial: 25377592
Drug: FTMB (0.5,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: FTMB (0.5, 1.5, 3.0, or 6.0 mg/kg)
Trial: 25377592
Drug: Herceptin(®) (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Herceptin(®) (6 mg/kg)
Trial: 20626050
Drug: Acupuncture treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Acupuncture treatment protocol including bilateral use of acupoints (Fengchi (GB20), Taiyang (EX‐HN5), etc.), manual stimulation, 30 minutes per session, 20 needles per session, total duration of at least 10 weeks, treatment frequency of twice a week with one week rest between the first 10 and last 10 sessions.
Trial: 10548704
Drug: Ketamine (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine (200 mg)
Trial: 10548704
Drug: Fentanyl (0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl (0.2 mg)
Trial: 14964737
Drug: Intramuscular lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intramuscular lidocaine
Trial: 30448246
Drug: Intralesional 5-fluorouracil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional 5-fluorouracil (5-FU) injections
Trial: 30566004
Drug: Liraglutide (1.8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide (1.8 mg or maximum tolerated dose)
Trial: 26743240
Drug: Exenatide (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exenatide (10 μg/day, n = 21)
Trial: 26743240
Drug: Liraglutide (0.3-0.9
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Liraglutide (0.3-0.9 mg/day, n = 19)
Trial: 25108586
Drug: iv-B (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iv-B (intravenous oxytocin when anterior shoulder seen)
Trial: 25108586
Drug: iv-A (intravenous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: iv-A (intravenous oxytocin after delivery of the fetus)
Trial: 25108586
Drug: im-A (intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: im-A (intramuscular oxytocin after delivery)
Trial: 25108586
Drug: im-B (intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: im-B (intramuscular oxytocin when anterior shoulder seen)
Trial: 21833852
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of ultrasonography and physical examination
Trial: 17324825
Drug: 20 mg
RxNorm normalized name: urea 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20 mg of epinastine hydrochloride
Trial: 17324825
Drug: 6 mg
RxNorm normalized name: boron 6 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 6 mg of chlorpheniramine maleate
Trial: 7890211
Drug: 10 mg
RxNorm normalized name: biotin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mg Isosorbide-5-mononitrate (Is-5-Mn)
Trial: 7890211
Drug: 40 mg
RxNorm normalized name: rutin 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 mg Isosorbide-5-mononitrate (Is-5-Mn)
Trial: 2197583
Drug: Preoperative controlled
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Preoperative controlled infusion of 10 mg Propionibacterium avidum KP‐40
Trial: 656269
Drug: Bumetanide (0.5-2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bumetanide (0.5-2 mg)
Trial: 656269
Drug: Frusemide (dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Frusemide (dose not specified)
Trial: 656269
Drug: Bumetanide and
RxNorm normalized name: bumetanide and potassium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bumetanide and Frusemide (high dosage in renal failure)
Trial: 25671798
Drug: Standard care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard care plus endovascular treatment with thrombectomy devices
Trial: 22308561
Drug: Treatment as
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Treatment as usual (waiting-list control)
Trial: 19178404
Drug: Amoxicillin hapten
RxNorm normalized name: Amoxicillin
DrugBank: Amoxicillin (DB01060)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Amoxicillin hapten
Trial: 11079280
Drug: Oral ondansetron
RxNorm normalized name: Ondansetron
DrugBank: Ondansetron (DB00904)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral ondansetron 16 mg plus dexamethasone 12 mg
Trial: 11079280
Drug: Oral granisetron
RxNorm normalized name: Granisetron
DrugBank: Granisetron (DB00889)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral granisetron 1 mg plus dexamethasone 12 mg
Trial: 8363029
Drug: Intravenous analgesia
RxNorm normalized name: Analgesic Balm GRX
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous analgesia with tramadol/metamizol (max. tramadol 400 mg+metamizol 5 g in any 24 h) after major surgery and additional administration of piritramide as needed (max. 60 mg/24 h.i.v.)
Trial: 8363029
Drug: Ibuprofen (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ibuprofen (3 x 500 mg) after minor surgery
Trial: 3012072
Drug: Smoking a
RxNorm normalized name: Publix Stop Smoking Aid 4mg Chewing Gum
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smoking a single 1-g marihuana cigarette containing 1.8% delta 9-tetrahydrocannabinol
Trial: 31366458
Drug: Positive airway
RxNorm normalized name: VersaPAP Positive Airway Pressure Device
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Positive airway pressure treatment
Trial: 17042168
Drug: Oral hygiene
RxNorm normalized name: HYDROGEN PEROXIDE 2.94 mL in 2.94 mL ORAL SPRAY [OROXID Forte Oral Hygiene]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral hygiene instruction (OHI) alone
Trial: 17042168
Drug: OHI and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OHI and metronidazole dental gel
Trial: 17042168
Drug: OHI and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: OHI and subgingival scaling plus metronidazole gel
Trial: 8801192
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid supplementation (500 mg twice daily for two weeks)
Trial: 1377455
Drug: Nalbuphine 1
RxNorm normalized name: nalbuphine 10 mg/mL injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nalbuphine 1 mg/kg i.v.
Trial: 30532779
Drug: Low-Level Laser
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-Level Laser Therapy (LLLT)